banner product

TESTS
 

 

A Rapid and Precise Diagnostic Test for the Detection of Ehrlichiosis in Dogs

 

 

Canine ehrlichiosis and anaplasmosis are two important tick-borne diseases that affect dogs and humans as well as other animal species world wide.

 

Originally in the same Ehrlichia group, Anaplasma has now been reclassified based on molecular method as a separated genera. These bacteria parasitizes in the blood cells of the host and cause variable degree of abnormalities, depending on the species involved and the immune response of the host. However the most common finding in these two organism is thrombocytopenia. Coinfection is possible and tend to worsen the disease condition and complicate the diagnose.

 

The QubeMDx provide diagnostic solutions to the most two common species in the clinical practice: 'Ehrlichia. canis' and 'Anaplasma. platys'


Dogs will appear perfectly normal for one to three weeks after being bitten by a tick carrying E. canis bacteria. If the dog is unable to fight off the infection during this time, he will enter what is known as the acute phase of infection.

 

Dogs can display a variety of symptoms during the acute phase of canine ehrlichiosis, including:

  • Fever
  • Lethargy
  • Poor appetite
  • Lymph node enlargement
  • Abnormal bruising and bleeding
  • Chronic eye inflammation

 

 

 

THE QubeMDx SOLUTION

Using a proprietary Polymerase Chain Reaction (PCR) technology, the QubeMDx performs the detection of CANINE EHRLICHIOSIS in only 15 minutes.

 

The QubeMDx is a real Point-of-Care solution that empowers the veterinarian with the right information, at the right time, so they can make the right decision and provide the best course of treatment for the animal.

  • Instant Detection of Ehrlichia Canis and Anaplasma Platys.
  • High Accuracy and Specificity.
  • Shorter Turnaround Time.
  • Faster Medical Decision.

solution advantages

 

DIAGNOSTIC PROCEDURE

 

CONTACT

We at Credo pioneer accessible diagnostic platforms to improve the lives of those we love. We believe providing the right information to the right people at the right time leads to better outcomes.